ProNephro AKI™ (NGAL) is now available through Roche Diagnostics.

Announcements

Investor News

BioPorto A/S

BioPorto Newsletter

Fri, 19 Dec 2025 10:39 GMT

BioPorto A/S

BioPorto Nyhedsbrev

Fri, 19 Dec 2025 10:39 GMT

BioPorto A/S

Changes to the Executive Management

Thu, 11 Dec 2025 16:31 GMT

BioPorto A/S

Ændringer i selskabets Direktion

Thu, 11 Dec 2025 16:31 GMT

BioPorto A/S

Managers’ transactions

Mon, 24 Nov 2025 09:38 GMT

BioPorto A/S

Ledende medarbejderes transaktioner

Mon, 24 Nov 2025 09:38 GMT

BioPorto A/S

BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes

Mon, 24 Nov 2025 09:09 GMT

BioPorto A/S

BioPorto A/S rejser ca. 43 mio. kr. i ny kapitalrunde - Ændring i antal aktier og stemmer

Mon, 24 Nov 2025 09:09 GMT

BioPorto A/S

BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued NGAL sales growth

Wed, 19 Nov 2025 06:32 GMT

BioPorto A/S

BioPortos delårsresultat for tredje kvartal 2025 – Fortsat fremdrift og fortsat øget NGAL-salgsvækst

Wed, 19 Nov 2025 06:32 GMT

BioPorto A/S

Private placement of 40,438,426 new shares fully subscribed – gross proceeds of approximately DKK 43 million to BioPorto A/S

Thu, 13 Nov 2025 22:13 GMT

BioPorto A/S

Rettet emission af 40.438.426 nye aktier fuldt tegnet – bruttoprovenu på cirka 43 mio. kr. til BioPorto A/S

Thu, 13 Nov 2025 22:13 GMT

BioPorto A/S

BioPorto Executes on its Financing Strategy- BioPorto A/S initiates pre-subscribed private placement

Thu, 13 Nov 2025 18:50 GMT

BioPorto A/S

BioPorto eksekverer på finansieringsstrategi – BioPorto A/S indleder forhåndstegnet rettet emission

Thu, 13 Nov 2025 18:50 GMT

BioPorto A/S

Business Strategy Update – the “Forward” Strategic Direction, Aspirations towards 2028 and Funding Needs

Tue, 04 Nov 2025 21:10 GMT

BioPorto A/S

Opdatering af forretningsstrategi – Strategien "Forward", aspirationer frem mod 2028 og finansieringsbehov

Tue, 04 Nov 2025 21:10 GMT

BioPorto A/S

Pre-announcement of the Key Financial Results for Third Quarter 2025 and Revised Guidance for 2025

Tue, 04 Nov 2025 21:08 GMT

BioPorto A/S

Forudgående offentliggørelse af de finansielle nøgletal for 3. kvartal 2025 og reviderede forventninger til regnskabsåret 2025

Tue, 04 Nov 2025 21:08 GMT

BioPorto A/S

Progress Update on BioPorto’s Adult Clinical Study

Tue, 04 Nov 2025 21:07 GMT

BioPorto A/S

Statusopdatering på BioPortos kliniske studie for voksne

Tue, 04 Nov 2025 21:07 GMT

Follow this link to view all historical announcements.